Literature DB >> 9389468

A cancer therapy resistant to resistance.

R S Kerbel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9389468     DOI： 10.1038/36978

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  52 in total

Review 1.  In situ dendritic cell vaccination for the treatment of glioma and literature review.

Authors:  Ming Li; Shuangyin Han; Xiwen Shi
Journal:  Tumour Biol       Date:  2015-08-29

Review 2.  Angiogenesis as a target for breast cancer therapy.

Authors:  D Rayson; S A Vantyghem; A F Chambers
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

3.  Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice.

Authors:  Dhanalakshmi Chinnasamy; Zhiya Yu; Marc R Theoret; Yangbing Zhao; Rajeev K Shrimali; Richard A Morgan; Steven A Feldman; Nicholas P Restifo; Steven A Rosenberg
Journal:  J Clin Invest       Date:  2010-10-11       Impact factor: 14.808

Review 4.  Establishing a link between oncogenes and tumor angiogenesis.

Authors:  R S Kerbel; A Viloria-Petit; F Okada; J Rak
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

Review 5.  RNA interference and its role in cancer therapy.

Authors:  Behzad Mansoori; Siamak Sandoghchian Shotorbani; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2014-08-10

6.  Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and (19)F MRI.

Authors:  Heling Zhou; Rami R Hallac; Ramona Lopez; Rebecca Denney; Matthew T MacDonough; Li Li; Li Liu; Edward E Graves; Mary Lynn Trawick; Kevin G Pinney; Ralph P Mason
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-01-15

Review 7.  Molecular mechanisms of tumor angiogenesis and tumor progression.

Authors:  U Cavallaro; G Christofori
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

8.  Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases.

Authors:  H N Lode; T Moehler; R Xiang; A Jonczyk; S D Gillies; D A Cheresh; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Human endostatin gene transfer, either naked or with liposome, has the same inhibitory effect on growth of mouse liver tumor cells in vivo.

Authors:  Chun-Hong Ma; Yan Zhang; Xiao-Yan Wang; Li-Fen Gao; Hua Liu; Chun Guo; Su-Xia Liu; Ying-Lin Cao; Li-Ning Zhang; Wen-Sheng Sun
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

10.  Tumor angiogenesis: insights and innovations.

Authors:  Fernando Nussenbaum; Ira M Herman
Journal:  J Oncol       Date:  2010-04-26       Impact factor: 4.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.